June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Misako Nagasaka Shares FDA Approval of Taletrectinib for ROS1-Positive NSCLC
Jun 13, 2025, 07:19

Misako Nagasaka Shares FDA Approval of Taletrectinib for ROS1-Positive NSCLC

Misako Nagasaka, Thoracic Oncologist at University of California Irvine, posted on X:

“Another option for patients!!
On June 11, 2025, the FDA approved taletrectinib (Ibtrozi, Nuvation Bio Inc.), a kinase inhibitor, for adults with locally advanced or metastatic ROS1-positive NSCLC.”

More posts featuring NSCLC.